SenExo-cCCT2 Reprograms Senescence Response and Anti-Tumor Immunity Following FOLFIRINOX Chemotherapy in Pancreatic Ductal Adenocarcinoma.
SenExo-cCCT2 可重编程胰腺导管腺癌 FOLFIRINOX 化疗后的衰老反应和抗肿瘤免疫。
期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202508431
Zhu Shuncang, Chen Yinhao, Lin Hongyi, Lu Jinpeng, Pan Yu, Li Ge, Wu Yongding, Zhang Haoxiang, Huang Xiaoxiao, Chen Yiting, Chen Huangjing, Jin Long, Huang Min, Liao Chengyu, Huang Long, Tian Yifeng, Wang Zuwei, Li Qiaowei, Chen Shi